Effects of salinomycin on cancer stem cell in human lung adenocarcinoma A549 cells

Medicinal Chemistry

Volumn 7, Issue 2, 2011, Pages 106-111

  Wang, Yi ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

A549 cells; Cancer stem cell; Lung adenocarcinoma; Salinomycin

Indexed keywords

ALDEHYDE DEHYDROGENASE; OCTAMER TRANSCRIPTION FACTOR 4; SALINOMYCIN; SULFORHODAMINE B; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; CANCER STEM CELL; COLONY FORMATION; CONCENTRATION RESPONSE; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 79952324919     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340611794859307     Document Type: Article

References (33)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Marray, T; Thun, M.J. Cancer statistics. CA Cancer J. Clin., 2008, 58, 71-96.
2. Edwards, B.K.; Ward, E.; Kohler, B.A. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer, 2010, 116, 544-573.
3. Ginestier, C.; Liu, S.; Diebel, M.E.; Korkaya, H.; Luo, M.; Brown, M.; Wicinski, J.; Cabaud, O.; Charafe-Jauffret, E.; Birnbaum, D.; Guan, J.; Dontu, G.; Max, S. Wicha:CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J. Clin. Invest., 2010, 120, 485-497.
4. Gupta, P.B.; Onder, T.T.; Jiang, G.; Tao, K.; Charlotte, K.; Weinberg, R.A.; Lander, E.S. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell, 2009, 138, 645-659.
5. Loizzo, M.R.; Said, A.; Tundis, R.; Hawas, U.W.; Rashed, K.; Menichini, F.; Frega, N.G.; Menichini, F. Antioxidant and antiproliferative activity of Diospyros lotus L. extract and isolated compounds. Plant. Foods. Hum. Nutr., 2009, 64, 264-270.
6. Franken, N.A.; Rodermond, H.M.; Stap. J.; Haveman, J.; van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc., 2006, 1, 2315-2319.
7. Croker, A.K.; Goodale, D.; Chu, J.; Postenka, C.; Hedley, B.D.; Hess, D.A.; Allan, A.L. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J. Cell. Mol. Med., 2009, 13, 2236-2252.
8. Zhang, M.; Behbod, F.; Atkinson, R.L.; Landis, M.D.; Kittrell, F.; Edwards, D.; Medina, D.; Tsimelzon, A.; Hilsenbeck, S.; Green, J.E.; Michalowska, A.M.; Rosen, J.M. Identification of tumorinitiating cells in a p53-null mouse model of breast cancer. Cancer. Res., 2008, 68, 4674-4682.
9. Byrne, J.A.; Pedersen, D.A.; Clepper, L.L.; Nelson, M.; Sanger, W.G.; Gokhale, S.; Wolf, D.P.; Mitalipov, S.M. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature, 2007, 450, 497-502. (Pubitemid 350190255)
10. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001, 25(4), 402-408. (Pubitemid 34164012)
11. Reva, T.; Morrison, S.J.; Clarke, M.F.; Weissman, I.L. Stem cells, cancer, and cancer stem cells. Nature, 2001, 414, 105-111. (Pubitemid 33041634)
12. Koch, U.; Krausea, M.; Baumann, M. Cancer stem cells at the crossroads of current cancer therapy failures-Radiation oncology Perspective. Semin. Cancer Biol., 2010, 20(2), 116-124.
13. Sládek, N.E.; Kollander, R.; Sreerama, L.; Kiang, D.T. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Cancer Chemother. Pharmacol., 2002, 49(4), 309-321. (Pubitemid 34253270)
14. Vasiliou, V.; Pappa, A.; Estey, T. Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism. Drug. Metab. Rev., 2004, 36(2), 279-299. (Pubitemid 38807313)
15. Ucar, D.; Cogle, C.R.; Zucali, J.R., Ostmark, B.; Scott, E.W.; Zori, R.; Gray, B.A.; Moreb, J.S. Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem-Biol. Interact., 2009, 178(1-3), 348-355.
16. Peacock, C.D.; Watkins, D.N. Cancer stem cells and the ontogeny of lung cancer. J. Clin. Oncol., 2008, 26(17), 2883-2889.
17. Charafe-Jauffret, E.; Ginestier, C.; Iovino, F.; Wicinski, J.; Cervera, N.; Finetti, P.; Hur, M.H.; Diebel, M.E.; Monville, F.; Dutcher, J.; Brown, M.; Viens, P.; Xerri, L.; Bertucci, F.; Stassi, G.; Dontu, G.; Birnbaum, D.; Wicha, M.S. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res., 2009, 69(4), 1302-1313.
18. Stingl, J.; Eirew P.; Ricketson, I.; Shackleton, M.; Vaillant, F.; Choi, D.; Li, H.I.; Eaves, C.J. Purification and unique properties of mammary epithelial stem cells. Nature, 2006, 439(7079), 993-997. (Pubitemid 43292419)
19. Ginestier, C.; Hur, M.H.; Charafe-Jauffret, E.; Monville, F.; Dutcher, J.; Brown, M.; Jacquemier, J.; Viens, P.; Kleer, C.G.; Liu, S.; Schott, A.; Hayes, D.; Birnbaum, D.; Wicha, M.S.; Dontu, G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell. Stem. Cell, 2007, 1(5), 555-567. (Pubitemid 350056407)
20. Rasheed, Z.A.; Yang, J.; Wang, Q.; Kowalski, J.; Freed, I.; Murter, C.; Hong, S.M.; Koorstra, J.B.; Rajeshkumar, N.V.; He, X.; Goggins, M.; Iacobuzio-Donahue, C.; Berman, D.M.; Laheru, D.; Jimeno, A.; Hidalgo, M.; Maitra, A.; Matsui, W. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J. Natl. Cancer Inst., 2010, 102(5), 340-351.
21. Charafe-Jauffret, E.; Monville, F.; Ginestier, G. Cancer stem cells in breast current opinion and future challenges. Pathobiology, 2008, 75(2), 75-84. (Pubitemid 351820725)
22. Ponti, D.; Costa, A.; Zaffaroni, N.; Pratesi, G.; Petrangolini, G.; Coradini, D.; Pilotti, S.; Pierotti, M.A.; Daidone, M.G. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res., 2005, 65(13), 5506-5511. (Pubitemid 40911148)
23. Eramo, A.; Lotti, F.; Sette, G. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell. Death. Differ., 2008, 15(3), 504-514. (Pubitemid 351267301)
24. Saito, S.; Liu, B.; Yokoyama, K. Animal embryonic stem (ES) cells: self-renewal, pluripotency, transgenesis and nuclear transfer. Hum. Cell., 2004, 17(3), 107-115.
25. Adachi, K.; Suemori, H.; Yasuda, S.Y.; Nakatsuji, N.; Kawase, E. Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Gene Cells, 2010, 15(5), 455-470.
26. Liu, T.; Xu, F.; Du, X.; Lai, D.; Liu, T.; Zhao, Y.; Huang, Q.; Jiang, L.; Huang, W.; Cheng, W.; Liu, Z. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22 RVE. Mol. Cell. Biochem., 2010, 340(1-2), 265-273.
27. Xu, X.L.; Xing, B.C.; Han, H.B.; Zhao, W.; Hu, M.H.; Xu, Z.L.; Li, J.Y.; Xie, Y.; Gu, J.; Wang, Y.; Zhang, Z.Q. The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor. Carcinogenesis, 2010, 31(2), 167-174.
28. Gidekel, S.; Pizov, G.; Bergman, Y.; Pikarsky, E. Oct-3/4 is a dosedependent oncogenic fate determinant. Cancer Cell, 2003, 4(5), 361-370. (Pubitemid 37491097)
29. Ling, T.Y.; Kuo M.D.; Li, C.L.; Yu, A.L.; Huang, Y.H.; Wu, T.J.; Lin, Y.C.; Chen, S.H.; Yu J. Identification of pulmonary OCT-4-stem-progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc. Natl. Acad. Sci. USA, 2006, 103(25), 9530-9535. (Pubitemid 43955859)
30. Levings, P.P.; McGarry, S.V.; Currie, T.P.; Nickerson, D.M.; McClellan, S.; Ghivizzani, S.C.; Steindler, D.A.; Gibbs, C.P. Expression of an exogenous human OCT-4 promoter identifies tumorinitiating cells in osteosarcoma. Cancer Res., 2009, 69(14), 5648-5655.
31. Chiou, S.H.; Yu, C.C.; Huang, C.Y.; Lin, S.C.; Liu, C.J.; Tsai, T.H.; Chou, S.H.; Chien, C.S.; Ku, H.H.; Lo, J.F. Positive correlations of OCT-4 and nanog in oral cancer stem-like cells and highgrade oral squamous cell carcinoma. Clin. Cancer Res., 2008, 14(13), 4085-4095.
32. Chen, Y.C.; Hsu, H.S.; Chen, Y.W.; Tsai, T.H.; How, C.K.; Wang, C.Y.; Hung, S.C.; Chang, Y.L.; Tsai, M.L.; Lee, Y.Y.; Ku, H.H.; Chiou, S.H. OCT-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS. One, 2008, 3(7), 2637.
33. Fuchs, D.; Daniel, V.; Sadeghi, M.; Opelz, G.; Naujokat, C. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem. Biophys. Res. Commun., 2010, 394(4), 1098-1104.